Response to Covid-19: An ethical imperative to build a resilient health system in India.
Indian J Med Ethics
; V(2): 1-4, 2020.
Article
in English
| MEDLINE | ID: covidwho-247829
ABSTRACT
China reported cases of a severe form of pneumonia in December 2019 from Wuhan city, Hubei province. The virus causing this illness was identified as the novel Coronavirus 2019, which has now been christened Covid-19. The illness is characterised by fever, cough, body pain and in a few cases, progression to acute respiratory distress syndrome (ARDS) which marks very serious damage to the lungs (1-4). Apart from Wuhan, China, the virus has spread to 26 other countries as on February 18, 2020. Of these 26 countries, the cases of Covid-19 have been exported directly from China in 23 of them. As on February 23, 2020, a total of 78,811 confirmed cases, 2445 deaths have been reported globally. The World Health Organization declared this as a Public Health Emergency of International Concern (PHEIC) on January 30, 2020 (5).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Delivery of Health Care
/
Clinical Governance
/
Pandemics
/
Health Resources
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Med Ethics
Journal subject:
Ethics
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS